ribavirin has been researched along with baicalein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chen, L; Dou, J; Guo, Q; Su, Z; Wang, H; Zhou, C; Zhou, H; Zhou, W | 1 |
| Li, N; Niu, F; Zhang, C | 1 |
3 other study(ies) available for ribavirin and baicalein
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice.
Topics: Administration, Oral; Animals; Antiviral Agents; Body Weight; Cell Culture Techniques; Cell Line; Dogs; Drug Combinations; Drug Synergism; Female; Flavanones; Influenza A Virus, H1N1 Subtype; Kidney; Lung; Mice; Mice, Inbred ICR; Orthomyxoviridae Infections; Ribavirin; Survival Rate; Viral Matrix Proteins; Virus Replication | 2011 |
Baicalein triazole prevents respiratory tract infection by RSV through suppression of oxidative damage.
Topics: Animals; Cytokines; Female; Flavanones; Interferon-beta; Interleukin-6; Interleukin-8; Lymphocytes; Mice; Mice, Inbred BALB C; Neutrophils; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pneumonia; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Ribavirin; STAT3 Transcription Factor; Triazoles; Tumor Necrosis Factor-alpha; Virus Replication | 2019 |